Bilgehan Dag is a highly accomplished pharmaceutical professional with a diverse background in marketing, regulatory affairs, and organic research. He obtained his Bachelor's degree in Chemistry from The University of Manchester and went on to study for an Executive Master's degree in Strategy and Management of Health Industries at ESSEC Business School. He also holds a Master's degree in Pharmaceutical Regulations from Universite de Strasbourg.

Bilgehan has held several key positions in some of the world's most respected pharmaceutical companies including his current role as Global Launch Lead, Amyloidosis at Alexion Pharmaceuticals, Inc. where he is responsible for overseeing the launch of a new product. Prior to this, he served as New Products Strategy and Associate Director, Global Marketing, Metabolic Franchise at Alexion Pharmaceuticals, Inc. In his former roles, he oversaw the EMEA Metabolic Franchise as Senior and Marketing Manager.

His expertise extends to a variety of roles such as Organic research at ECPM Strasbourg and Drug Regulatory Affairs at GSK. Additionally, he has experience in Immunology as a Marketing Brand & Customer Manager at Merck. His diverse background makes him a highly sought after professional in the pharmaceutical industry.